AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

CRISPR Therapeutics, Inc Tech Stack and Enterprise Applications

CRISPR Therapeutics, Inc ERP
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Oracle Legacy Oracle Cloud ERP ERP Financial ERP n/a 2018 2019
In 2018, CRISPR Therapeutics, Inc implemented Oracle Cloud ERP in an ERP Financial deployment to centralize corporate accounting, general ledger and consolidation for the finance organization. The implementation targeted the Finance group and a global consolidating environment, supporting accounting for international operations, intercompany transactions and inventory accounting activities. Oracle Cloud ERP was configured to support core financial modules including general ledger, journal entry processing, balance sheet reconciliations and month end close orchestration. Functional configuration emphasized inventory accounting flows, intercompany accounting rules and schedule generation to support quarterly and annual financial audits, aligning system workflows with GAAP accounting responsibilities. Operational workflows connected Oracle Cloud ERP to FP&A collaboration for post close variance analysis and to audit preparation through structured schedule and document outputs. Day to day activities required finance personnel to prepare and process journal entries into Oracle Fusion as the operational ledger interface, while the system supported consolidations and cross border accounting procedures across corporate finance and accounting functions. Governance around the deployment reinforced month end close ownership, standardized reconciliation schedules and strengthened internal control processes, with the Sr. Manager Accounting and Sr. Director Finance owning process design. The implementation also built in capacity for ad hoc projects and workflow process improvements to sustain finance controls, audit readiness and ongoing liaison between accounting and FP&A.
CRISPR Therapeutics, Inc AI-Powered Application
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Rocket.chat Legacy Rocket.chat Chatbots and Conversational AI AI-Powered Application n/a 2018 2018
In 2018 CRISPR Therapeutics, Inc deployed Rocket.chat as a web-embedded conversational interface within the Chatbots and Conversational AI category. Rocket.chat is present on the corporate website to provide a real-time messaging channel for site visitors and external stakeholders, implemented as an embeddable browser client that surfaces conversational interactions directly on public pages. Functional capabilities implemented with Rocket.chat include a web chat widget, real-time messaging, channel-based routing, and administrative moderation and configuration, consistent with standard Chatbots and Conversational AI workflows. Operational scope is focused on public facing website engagement, with the platform positioned to capture external inquiries and route conversations to internal teams, and governance administered through Rocket.chat configuration and moderation controls supporting conversation management on the CRISPR Therapeutics, Inc website.
CRISPR Therapeutics, Inc Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2015 2015
In 2015, CRISPR Therapeutics, Inc implemented Microsoft 365 as a Collaboration platform. The corporate website references Microsoft 365 assets, indicating organization-wide use of cloud-hosted productivity services and public-facing integration points for content and collaboration. The Microsoft 365 deployment centers on cloud tenant architecture and provides core Collaboration capabilities including Exchange Online email, SharePoint Online document management, OneDrive for Business file sync, and Microsoft Teams for synchronous and asynchronous collaboration. Governance and access controls align with centralized identity and access management and role-based permissions, supporting research, corporate operations, and administrative functions through integrated messaging, document management, and team collaboration workflows.
CRISPR Therapeutics, Inc Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application, Web and Enterprise Search Content Management 2020 2020
Digital Signing Content Management 2021 2021
Web Content Management Content Management 2018 2018
CRISPR Therapeutics, Inc CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Customer Experience CRM 2020 2020
CRISPR Therapeutics, Inc Procurement
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Procurement Procurement 2018 2018
CRISPR Therapeutics, Inc IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2014 2014
CRISPR Therapeutics, Inc CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Identity and Access Management (IAM) CyberSecurity 2021 2021
Secure Email Gateways (SEGs) CyberSecurity 2018 2018

IT Decision Makers and Key Stakeholders at CRISPR Therapeutics, Inc

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by CRISPR Therapeutics, Inc Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from CRISPR Therapeutics, Inc IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the CRISPR Therapeutics, Inc digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD CRISPR Therapeutics, Inc Technographics
CRISPR Therapeutics, Inc is a Life Sciences organization based in Switzerland, with around 458 employees and annual revenues of $439.0 million.
CRISPR Therapeutics, Inc operates a diverse technology stack with applications such as Oracle Cloud ERP, Rocket.chat and Microsoft 365, covering areas like ERP Financial, Chatbots and Conversational AI and Collaboration.
CRISPR Therapeutics, Inc has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Oracle, Rocket.chat and Microsoft.
CRISPR Therapeutics, Inc recently adopted applications including DocuSign eSignature in 2021, Okta Identity Cloud in 2021 and Algolia Search in 2020, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of CRISPR Therapeutics, Inc’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates CRISPR Therapeutics, Inc’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete CRISPR Therapeutics, Inc technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.